VeonGen says FDA aligned on pivotal Phase 3 plan for VG801 in Stargardt disease
Regulatory agreement on the pivotal design clears a path toward late-stage testing in the inherited retinal condition.
Read at The Manila Times โRegulatory agreement on the pivotal design clears a path toward late-stage testing in the inherited retinal condition.
Read at The Manila Times โ